Concepedia

Johanna A. Kremer Hovinga

JA

Statistics

Publications

90

Citations

9.1K

H-Index

50

Active since

1995

Affiliations

University Hospital of Bern(Current)

University of Bern

University College London

University of Oklahoma Health Sciences Center

Medical University of Vienna

Johanna A. Kremer Hovinga is an author at University Hospital of Bern specializing in hematology, medicine, and thrombosis.

ORCID

Publications per year

1995–2024

90

Publications

90

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

Marie Scully, Spero R. Cataland, Flora Peyvandi et al. · New England Journal of Medicine · 2019 · 999 citations · Full text

, , +17

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

Flora Peyvandi, Marie Scully, Johanna A. Kremer Hovinga et al. · New England Journal of Medicine · 2016 · 658 citations · Full text

, , +17

Survival and relapse in patients with thrombotic thrombocytopenic purpura

Johanna A. Kremer Hovinga, Sara K. Vesely, Deirdra R. Terrell et al. · Blood · 2009 · 570 citations · Full text

, , +8

Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies

Marie Scully, Spero R. Cataland, Paul Coppo et al. · Journal of Thrombosis and Haemostasis · 2016 · 494 citations · Full text

, , +11

The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency

Deirdra R. Terrell, Lauren A. Williams, Sara K. Vesely et al. · Journal of Thrombosis and Haemostasis · 2005 · 334 citations

, , +8

1–5 of 90